A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases
Public ClinicalTrials.gov record NCT05755035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Prospective, Open-label, Randomized, Crossover Study to Evaluate Pharmacokinetics (PK), Safety, and Tolerability of TAK-881 in Primary Immunodeficiency Diseases (PIDD)
Study identification
- NCT ID
- NCT05755035
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- HYQVIA Biological
- TAK-881 Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2023
- Primary completion
- Jan 19, 2026
- Completion
- Jan 19, 2026
- Last update posted
- Feb 2, 2026
2023 – 2026
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Irvine Medical Center | Irvine | California | 92697 | — |
| Allergy and Asthma Clinical Research | Walnut Creek | California | 94598 | — |
| National Jewish Medical And Research Center | Denver | Colorado | 80206 | — |
| University of South Florida | St. Petersburg | Florida | 33701 | — |
| Central Georgia Infectious Disease Consultants | Macon | Georgia | 31201 | — |
| Rush University Medical Center - University Cardiovascular Surgeons | Chicago | Illinois | 60612-3852 | — |
| Sneeze, Wheeze, & Itch Associates, LLC | Normal | Illinois | 61761 | — |
| Louisiana State University Health Science Center-New Orleans | New Orleans | Louisiana | 70118 | — |
| Northwell Health | Great Neck | New York | 11021 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Duke Asthma, Allergy and Airway Center | Durham | North Carolina | 27705 | — |
| Optimed Research, LTD | Columbus | Ohio | 43235 | — |
| Vital Prospects Clinical Research Institute, PC | Tulsa | Oklahoma | 74136 | — |
| Allergy Partners of North Texas | Dallas | Texas | 75230 | — |
| Tanner Clinic | Murray | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05755035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05755035 live on ClinicalTrials.gov.